| | | | | | S-1 | | | |
| | | | | | S-1 | | | |
| | | | | | S-2 | | | |
| | | | | | S-2 | | | |
| | | | | | S-3 | | | |
| | | | | | S-5 | | | |
| | | | | | S-7 | | | |
| | | | | | S-12 | | | |
| | | | | | S-20 | | | |
| | | | | | S-21 | | | |
| | | | | | S-22 | | | |
| | | | | | S-40 | | | |
| | | | | | S-41 | | | |
| | | | | | S-46 | | | |
| | | | | | S-47 | | | |
| | EXPERTS | | | | | S-47 | | |
| | | | | | 2 | | | |
| | | | | | 2 | | | |
| | | | | | 2 | | | |
| | | | | | 3 | | | |
| | | | | | 3 | | | |
| | | | | | 3 | | | |
| | | | | | 4 | | | |
| | | | | | 8 | | | |
| | | | | | 14 | | | |
| | | | | | 15 | | | |
| | | | | | 17 | | | |
| | | | | | 18 | | | |
| | | | | | 18 | | | |
| | | | | | 19 | | | |
| | | | | | 20 | | | |
| | | | | | 20 | | | |
| | | | | | 20 | | | |
| | | | | | 21 | | |
| | | |
As of March 31, 2022
|
| |||||||||
|
(Dollars in thousands)
|
| |
Actual
|
| |
As adjusted
for this offering |
| ||||||
|
Cash and Cash Equivalents
|
| | | $ | 144,255 | | | | | $ | | | |
| Liabilities and Shareholders’ Equity: | | | | | | | | | | | | | |
| Deposits: | | | | | | | | | | | | | |
|
Non-interest bearing demand
|
| | | $ | 710,697 | | | | | | | | |
|
Interest-bearing demand
|
| | | | 554,235 | | | | | | | | |
|
Savings
|
| | | | 1,632,690 | | | | | | | | |
|
Time of $250 or more
|
| | | | 46,486 | | | | | | | | |
|
Other time
|
| | | | 147,144 | | | | | | | | |
|
Total deposits
|
| | | | 3,091,252 | | | | | | | | |
|
Subordinated notes, net
|
| | | | 20,468 | | | | | | | | |
|
Federal Home Loan Bank advances
|
| | | | 125,000 | | | | | | | | |
|
Long-term debt
|
| | | | 51,486 | | | | | | | | |
|
% Notes offered hereby(1)
|
| | | | — | | | | |
|
(3)
|
| |
|
Accrued expenses and other liabilities
|
| | | $ | 22,383 | | | | | | | | |
|
Total liabilities
|
| | | $ | 3,310,589 | | | | | | | | |
| Shareholders’ Equity: | | | | | | | | | | | | | |
|
Common stock, no par value (50,000,000 shares authorized; 16,631,413 shares issued at March 31, 2022)
|
| | | | 3,000 | | | | | | | | |
|
Preferred stock, $0.01 par value (50,000,000 shares authorized and no shares
outstanding at March 31, 2022) |
| | | | — | | | | | | | | |
|
Additional paid-in capital
|
| | | | 29,421 | | | | | | | | |
|
Retained earnings
|
| | | | 246,827 | | | | | | | | |
|
Accumulated other comprehensive loss
|
| | | | (42,768) | | | | | | | | |
|
Total stockholders’ equity
|
| | | | 236,480 | | | | | | | | |
|
Total liabilities and shareholders’ equity
|
| | | $ | 3,547,069 | | | | | | | | |
| Capital Ratios(2) | | | | | | | | | | | | | |
|
Common equity Tier 1 capital ratio
|
| | | | 9.16% | | | | | | % | | |
|
Tier 1 risk-based capital ratio
|
| | | | 9.81% | | | | | | % | | |
|
Total risk-based capital ratio
|
| | | | 10.72% | | | | | | % | | |
|
Tier 1 leverage ratio
|
| | | | 8.39% | | | | | | % | | |
| | | |
Per Note
|
| |
Total
|
| ||||||
|
Public offering price(1)
|
| | | | % | | | | | $ | | | |
|
Underwriting discounts and commissions paid by us(2)
|
| | | | % | | | | | $ | | | |
|
Proceeds to us, before expenses
|
| | | | % | | | | | $ | | | |
| | | | | | 2 | | | |
| | | | | | 2 | | | |
| | | | | | 2 | | | |
| | | | | | 3 | | | |
| | | | | | 3 | | | |
| | | | | | 3 | | | |
| | | | | | 4 | | | |
| | | | | | 8 | | | |
| | | | | | 14 | | | |
| | | | | | 15 | | | |
| | | | | | 17 | | | |
| | | | | | 18 | | | |
| | | | | | 18 | | | |
| | | | | | 19 | | | |
| | | | | | 20 | | | |
| | | | | | 20 | | | |
| | | | | | 20 | | | |
| | | | | | 21 | | |